Is risk of central nervous system (CNS) relaspse related to adjuvant taxane treatment in node-positive breast cancer?Results of the CNS substudy in the intergroup phase III BIG 02-98 trial
Material type:
TextSeries: Staff Publications ; Staff Publications- Crown, JohnPublication details: 2008DDC classification: - PUBLICATIONS ARCHIVE CROW
| Item type | Current library | Home library | Shelving location | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|---|
| 2 Week Loan | St. Luke’s Radiation Oncology Network Dublin | St. Luke’s Radiation Oncology Network Dublin | AR | PUBLICATIONS ARCHIVE CROW (Browse shelf(Opens below)) | Available | 39015000019193 |
Total holds: 0
Browsing St. Luke’s Radiation Oncology Network Dublin shelves, Shelving location: AR Close shelf browser (Hides shelf browser)
| PUBLICATIONS ARCHIVE COFF Pentoxifylline to treat radiation proctitis: a small and inconclusive randomised trial | PUBLICATIONS ARCHIVE CROW MDR1/P-glycoprotein and MRP-1 Drug Efflux Pumps in Pancreatic Carcinoma | PUBLICATIONS ARCHIVE CROW Adjuvent chemotherapy with sequential or concurrent anthracycline and docetaxel: breast international group 02-98 radomized trial | PUBLICATIONS ARCHIVE CROW Is risk of central nervous system (CNS) relaspse related to adjuvant taxane treatment in node-positive breast cancer?Results of the CNS substudy in the intergroup phase III BIG 02-98 trial | PUBLICATIONS ARCHIVE CROW Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer. | PUBLICATIONS ARCHIVE CTRU Emergency first presentation of colorectal cancer predicts significantly poorer outcomes: a review of 356 consecutive Irish patients | PUBLICATIONS ARCHIVE FAUL Cervical Cancer Treatment |
There are no comments on this title.
Log in to your account to post a comment.